Latest Insider Transactions at Vor Biopharma Inc. (VOR)
This section provides a real-time view of insider transactions for Vor Biopharma Inc. (VOR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Vor Biopharma Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Vor Biopharma Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 10
2025
|
Reprogrammed Interchange LLC |
SELL
Open market or private sale
|
Direct |
350,000
-1.01%
|
$350,000
$1.82 P/Share
|
|
Sep 09
2025
|
Reprogrammed Interchange LLC |
SELL
Open market or private sale
|
Direct |
449,226
-1.28%
|
$898,452
$2.0 P/Share
|
|
Sep 08
2025
|
Reprogrammed Interchange LLC |
SELL
Open market or private sale
|
Direct |
464,421
-1.31%
|
$464,421
$1.99 P/Share
|
|
Sep 05
2025
|
Reprogrammed Interchange LLC |
SELL
Open market or private sale
|
Direct |
400,000
-1.11%
|
$400,000
$1.97 P/Share
|
|
Sep 04
2025
|
Reprogrammed Interchange LLC |
SELL
Open market or private sale
|
Direct |
453,016
-1.25%
|
$453,016
$1.93 P/Share
|
|
Sep 03
2025
|
Reprogrammed Interchange LLC |
SELL
Open market or private sale
|
Direct |
554,612
-1.5%
|
$1,109,224
$2.0 P/Share
|
|
Aug 28
2025
|
Reprogrammed Interchange LLC |
SELL
Open market or private sale
|
Direct |
806,351
-2.14%
|
$1,612,702
$2.01 P/Share
|
|
Aug 27
2025
|
Reprogrammed Interchange LLC |
SELL
Open market or private sale
|
Direct |
611,647
-1.6%
|
$1,223,294
$2.01 P/Share
|
|
Aug 26
2025
|
Reprogrammed Interchange LLC |
SELL
Open market or private sale
|
Direct |
284,190
-0.74%
|
$568,380
$2.08 P/Share
|
|
Aug 25
2025
|
Reprogrammed Interchange LLC |
SELL
Open market or private sale
|
Direct |
387,346
-0.99%
|
$774,692
$2.12 P/Share
|
|
Jul 17
2025
|
Qing Che Zuraw Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
937,080
+50.0%
|
-
|
|
Jul 09
2025
|
Sandesh Mahatme CFO |
BUY
Grant, award, or other acquisition
|
Direct |
13,882,750
+50.0%
|
-
|
|
May 06
2025
|
Tirtha Chakraborty Chief Sci Off & Head Tech Ops |
SELL
Payment of exercise price or tax liability
|
Direct |
876
-0.4%
|
$0
$0.56 P/Share
|
|
May 06
2025
|
Robert Ang PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,361
-0.26%
|
$0
$0.56 P/Share
|
|
May 01
2025
|
Han Wook Choi Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,061
-3.86%
|
$0
$0.66 P/Share
|
|
May 01
2025
|
Robert Ang PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,273
-0.29%
|
$0
$0.66 P/Share
|
|
May 01
2025
|
Tirtha Chakraborty Chief Sci Off & Head Tech Ops |
SELL
Payment of exercise price or tax liability
|
Direct |
1,947
-0.44%
|
$0
$0.66 P/Share
|
|
Feb 13
2025
|
Eyal C. Attar CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,227
-1.73%
|
$2,227
$1.42 P/Share
|
|
Feb 10
2025
|
Eyal C. Attar CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,554
-1.94%
|
$2,554
$1.37 P/Share
|
|
Feb 06
2025
|
Eyal C. Attar CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,180
-0.89%
|
$1,180
$1.5 P/Share
|
|
Feb 06
2025
|
Robert Ang PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,787
-0.3%
|
$2,787
$1.5 P/Share
|
|
Feb 06
2025
|
Tirtha Chakraborty Chief Sci Off & Head Tech Ops |
SELL
Payment of exercise price or tax liability
|
Direct |
1,033
-0.47%
|
$1,033
$1.5 P/Share
|
|
Feb 03
2025
|
Han Wook Choi Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
52,500
+50.0%
|
-
|
|
Feb 03
2025
|
Eyal C. Attar CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
52,500
+28.37%
|
-
|
|
Feb 03
2025
|
Eyal C. Attar CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,353
-1.66%
|
$1,353
$1.34 P/Share
|
|
Feb 03
2025
|
Tirtha Chakraborty Chief Sci Off & Head Tech Ops |
BUY
Grant, award, or other acquisition
|
Direct |
52,500
+19.18%
|
-
|
|
Feb 03
2025
|
Tirtha Chakraborty Chief Sci Off & Head Tech Ops |
SELL
Payment of exercise price or tax liability
|
Direct |
1,163
-0.68%
|
$1,163
$1.34 P/Share
|
|
Feb 03
2025
|
Robert Ang PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
137,500
+12.98%
|
-
|
|
Feb 03
2025
|
Robert Ang PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,248
-0.41%
|
$3,248
$1.34 P/Share
|
|
Dec 30
2024
|
Reprogrammed Interchange LLC |
BUY
Open market or private purchase
|
Direct |
38,974,101
+50.0%
|
-
|
|
Dec 30
2024
|
Ra Capital Management, L.P. |
BUY
Grant, award, or other acquisition
|
Indirect |
16,897,159
+30.88%
|
-
|
|
Dec 27
2024
|
Eyal C. Attar CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,334
-11.26%
|
$10,334
$1.25 P/Share
|
|
Nov 06
2024
|
Tirtha Chakraborty Chief Sci Off & Head Tech Ops |
SELL
Payment of exercise price or tax liability
|
Direct |
875
-0.51%
|
$0
$0.86 P/Share
|
|
Nov 06
2024
|
Robert Ang PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,361
-0.3%
|
$0
$0.86 P/Share
|
|
Nov 06
2024
|
Eyal C. Attar CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
999
-1.08%
|
$0
$0.86 P/Share
|
|
Nov 06
2024
|
Amy Quinlan Vice President of Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
206
-0.41%
|
$0
$0.86 P/Share
|
|
Nov 01
2024
|
Robert Ang PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,751
-0.35%
|
$0
$0.8 P/Share
|
|
Nov 01
2024
|
Eyal C. Attar CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,146
-1.22%
|
$0
$0.8 P/Share
|
|
Nov 01
2024
|
Tirtha Chakraborty Chief Sci Off & Head Tech Ops |
SELL
Payment of exercise price or tax liability
|
Direct |
986
-0.57%
|
$0
$0.8 P/Share
|
|
Nov 01
2024
|
Amy Quinlan Vice President of Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
343
-0.67%
|
$0
$0.8 P/Share
|
|
Sep 03
2024
|
Amy Quinlan Vice President of Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
4,402
-7.97%
|
$0
$0.83 P/Share
|
|
Sep 03
2024
|
Robert Ang PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
12,657
-1.57%
|
$0
$0.83 P/Share
|
|
Sep 03
2024
|
Tirtha Chakraborty Chief Sci Off & Head Tech Ops |
SELL
Payment of exercise price or tax liability
|
Direct |
5,576
-3.14%
|
$0
$0.83 P/Share
|
|
Aug 06
2024
|
Amy Quinlan Vice President of Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
206
-0.37%
|
$0
$0.87 P/Share
|
|
Aug 06
2024
|
Robert Ang PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,361
-0.29%
|
$0
$0.87 P/Share
|
|
Aug 06
2024
|
Eyal C. Attar CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
999
-1.05%
|
$0
$0.87 P/Share
|
|
Aug 06
2024
|
Tirtha Chakraborty Chief Sci Off & Head Tech Ops |
SELL
Payment of exercise price or tax liability
|
Direct |
876
-0.49%
|
$0
$0.87 P/Share
|
|
Aug 01
2024
|
Amy Quinlan Vice President of Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
343
-0.61%
|
$0
$0.94 P/Share
|
|
Aug 01
2024
|
Tirtha Chakraborty Chief Sci Off & Head Tech Ops |
SELL
Payment of exercise price or tax liability
|
Direct |
985
-0.55%
|
$0
$0.94 P/Share
|
|
Aug 01
2024
|
Eyal C. Attar CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,146
-1.19%
|
$0
$0.94 P/Share
|